NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/03/2025
Voltar para busca
Dado oficial do USPTO
UNIBODY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
21/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
19/10/2006
Data de registro
16/10/2007
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/05/2018
Última transação
05/06/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
84
Localização do titular
DK
Examinador
GUTTADAURO, JULIE MARIE
Unidade examinadora
L60
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Genmab A/S
Representantes
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemicalsnamely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancerAIDS (acquired immune deficiency syndrome)other infectious diseasesimmune and autoimmune diseasesinflammatory diseases and cardiovascular diseases
Classe 5
Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancerAIDS (acquired immune deficiency syndrome) and other infections diseasesimmune and autoimmune diseasesinflammatory diseases and cardiovascular diseases
Classe 42
Medical and scientific researchnamely biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancerAIDS (acquired immune deficiency syndrome) and other infectious diseasesimmune and autoimmune diseasesinflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitationpatent licensing; licensing of intellectual property in the field of medicine; computer programmingnamely programming of computers for the collection and processing of medical data in medical scientific researchdevelopment and therapy with monoclonal antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/06/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/06/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
15/09/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/05/2018
71AG
REGISTERED-SEC.71 ACCEPTED
03/05/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/05/2018
ES71
TEAS SECTION 71 RECEIVED
16/04/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/10/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/09/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/04/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/02/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/02/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/11/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
12/05/2014
71AG
REGISTERED-SEC.71 ACCEPTED
12/05/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/05/2014
71AF
REGISTERED-SEC.71 FILED
16/04/2014
ES71
TEAS SECTION 71 RECEIVED
16/04/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/11/2011
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
15/07/2010
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/05/2009
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
08/05/2008
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/05/2008
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/01/2008
FIMP
FINAL DISPOSITION PROCESSED
28/01/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/01/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
16/10/2007
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
27/09/2007
PUBO
PUBLISHED FOR OPPOSITION
31/07/2007
NPUB
NOTICE OF PUBLICATION
11/07/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
26/06/2007
ALIE
ASSIGNED TO LIE
25/06/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/06/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
31/05/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/05/2007
ALIE
ASSIGNED TO LIE
31/05/2007
PAPER RECEIVED
14/05/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2007
FAXX
FAX RECEIVED
09/05/2007
RFNP
REFUSAL PROCESSED BY IB
29/03/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/03/2007
RFRR
REFUSAL PROCESSED BY MPU
13/03/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/03/2007
CNRT
NON-FINAL ACTION WRITTEN
10/03/2007
DOCK
ASSIGNED TO EXAMINER
04/03/2007
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
02/03/2007
NWAP
NEW APPLICATION ENTERED
01/03/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/03/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UNIBODY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.